CYP 3.92% 24.5¢ cynata therapeutics limited

Going forward..., page-1406

  1. 4,114 Posts.
    lightbulb Created with Sketch. 1404
    So if the deal does not go through this week, than Ross McDonald should pick the phone and give these guys a call.

    Allogeneic transplants

    Allogeneic transplants are performed using donor tissue from someone who is genetically suitable, often a close family member. The stem cells may be sourced from peripheral blood, bone marrow, or cord blood. When a perfect genetic match cannot be located, a mismatched allogeneic transplant may also be performed. In this case, the stem cells are sourced from peripheral blood and must undergo a refinement process to compensate for the riskier mismatch.

    A possible advantage of allogeneic transplants is that the donor stem cells create their own immune cells, which may help to kill cancer kills that remain in your body after treatment. However, graft-versus-host disease is a risk when performing allogeneic transplants.

    https://www.shebaonline.org/hemato-oncology/stem-cell-bone-marrow-transplantation-adults-and-children/

    What happened to the statement Multiple shoots on target.

    Regards

    Rossi70

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $44.01M
Open High Low Value Volume
25.5¢ 25.5¢ 24.5¢ $23.65K 94.55K

Buyers (Bids)

No. Vol. Price($)
1 40000 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 36715 1
View Market Depth
Last trade - 15.10pm 29/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.